| Dr Jay Edward Brown, MD | |
|
1215 Duff Ave, Ames, IA 50010-5400 | |
| (515) 239-4482 | |
| (515) 239-4732 |
| Full Name | Dr Jay Edward Brown |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 36 Years |
| Location | 1215 Duff Ave, Ames, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790772069 | NPI | - | NPPES |
| 0110452 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 29844 (Iowa) | Secondary |
| 207K00000X | Allergy & Immunology | 39501 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
Drugs commonly used to treat high blood pressure, and prevent heart attacks and strokes, are associated with significantly worse cardiovascular outcomes in hypertensive African Americans compared to whites, according to a new comparative effectiveness research study led by researchers in the Department of Population Health at NYU Langone Medical Center.
In a study published online by JAMA Ophthalmology, Malvina Eydelman, M.D., of the U.S. Food and Drug Administration, Silver Spring, Md., and colleagues examined the frequency of patient-reported visual symptoms, dry eye symptoms, satisfaction with vision, and satisfaction with laser insitu keratomileusis (LASIK) surgery in the Patient-Reported Outcomes With LASIK (PROWL) studies.
› Verified 1 days ago
| Entity Name | Mcfarland Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20031106000338 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
Drugs commonly used to treat high blood pressure, and prevent heart attacks and strokes, are associated with significantly worse cardiovascular outcomes in hypertensive African Americans compared to whites, according to a new comparative effectiveness research study led by researchers in the Department of Population Health at NYU Langone Medical Center.
In a study published online by JAMA Ophthalmology, Malvina Eydelman, M.D., of the U.S. Food and Drug Administration, Silver Spring, Md., and colleagues examined the frequency of patient-reported visual symptoms, dry eye symptoms, satisfaction with vision, and satisfaction with laser insitu keratomileusis (LASIK) surgery in the Patient-Reported Outcomes With LASIK (PROWL) studies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jay Edward Brown, MD 1215 Duff Ave, Ames, IA 50010-5400 Ph: (515) 239-4482 | Dr Jay Edward Brown, MD 1215 Duff Ave, Ames, IA 50010-5400 Ph: (515) 239-4482 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
Drugs commonly used to treat high blood pressure, and prevent heart attacks and strokes, are associated with significantly worse cardiovascular outcomes in hypertensive African Americans compared to whites, according to a new comparative effectiveness research study led by researchers in the Department of Population Health at NYU Langone Medical Center.
In a study published online by JAMA Ophthalmology, Malvina Eydelman, M.D., of the U.S. Food and Drug Administration, Silver Spring, Md., and colleagues examined the frequency of patient-reported visual symptoms, dry eye symptoms, satisfaction with vision, and satisfaction with laser insitu keratomileusis (LASIK) surgery in the Patient-Reported Outcomes With LASIK (PROWL) studies.
› Verified 1 days ago
Dr. Jason Allen Cascio, MD, PHD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4400 | |
Dr. Edward George Nassif, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4482 Fax: 515-239-4732 |